| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2013 | CN102871958A Medicinal composition containing monoammonium glycyrrhizinate compound and preparation method thereof |
| 01/16/2013 | CN102871957A Dexibuprofen intravenous administration preparation and preparation method thereof |
| 01/16/2013 | CN102871956A Propranolol hydrochloride gel for treating infant superficial hemangioma |
| 01/16/2013 | CN102871955A Ointment medicament composition containing mupirocin |
| 01/16/2013 | CN102871954A Lanoconazole emulsifiable paste and preparation method of lanoconazole emulsifiable paste |
| 01/16/2013 | CN102871953A Super-absorbent adsorption suppository |
| 01/16/2013 | CN102871952A Flurbiprofen acetaminophen ester solid dispersion and preparation method thereof |
| 01/16/2013 | CN102871951A Hyaluronic acid nano microgel loaded with anti-cancer medicine and preparation method for hyaluronic acid nano microgel |
| 01/16/2013 | CN102871950A 一种熊果酸固体分散体及其制备方法 One kind of ursolic acid solid dispersion and its preparation method |
| 01/16/2013 | CN102871919A Chinese medicinal herb weight losing cream |
| 01/16/2013 | CN102871860A Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 01/16/2013 | CN102871857A Synthesis of a nitroxide antioxidant and methods of use in cosmetic and dermatological compositions |
| 01/16/2013 | CN102871116A Traditional Chinese medicine type blood sugar-lowering health care food |
| 01/16/2013 | CN102441000B Anti-cancer anti-disease buccal tablet |
| 01/16/2013 | CN102423309B Drug composition for treating vomiting |
| 01/16/2013 | CN102397245B Nicardipine hydrochloride glucose injection |
| 01/16/2013 | CN102379853B Vidarabine monophosphate freeze-dried powder injection and preparation method thereof |
| 01/16/2013 | CN102362855B Itraconazole isomer oral liquid |
| 01/16/2013 | CN102357072B Injection preparation of T-2 lienomycin |
| 01/16/2013 | CN102349892B High-content vitamin C tablets and preparation method thereof |
| 01/16/2013 | CN102337297B Mbr-FPGS (folylpolyglutamate synthetase) efficient expression vector and construction method and application thereof |
| 01/16/2013 | CN102335119B New preparation for chemotherapy on tumor vascular thrombosis mediated by biological effect of ultrasound |
| 01/16/2013 | CN102295772B Monomethoxy polyethylene glycol-poly(L-tryptophan) amphipathic segmented copolymer, preparation method thereof and preparation method of drug loaded miceller solution thereof |
| 01/16/2013 | CN102274197B Ganciclovir composition for injection and preparation method thereof |
| 01/16/2013 | CN102266291B Preparation method of strychnine immune nanoparticles |
| 01/16/2013 | CN102251317B Preparation method of electrospun fibers with controllable drug release |
| 01/16/2013 | CN102247322B Octacosanol micro-emulsion and preparation method thereof |
| 01/16/2013 | CN102232946B Use of antrodia camphorata cyclohexenone compound in preparing medicine for inhibiting stomach cancer tumor cell growth |
| 01/16/2013 | CN102228517B Plantain seed extract and application thereof |
| 01/16/2013 | CN102228469B Nano-selenium particles and preparation method thereof |
| 01/16/2013 | CN102228425B Tumor-targeted magnetic hydrogel nanoscale medicine delivery system and construction method and application thereof |
| 01/16/2013 | CN102225095B Effective fraction of plantain seeds as well as preparation method and application thereof |
| 01/16/2013 | CN102225083B Pharmaceutical composition for treating hypertension and hyperlipidemia, and application thereof |
| 01/16/2013 | CN102190612B Endophytic fungus diterpene alkaloid compound of natural seaweed as well as preparation method and application thereof |
| 01/16/2013 | CN102180928B 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof |
| 01/16/2013 | CN102178813B Slimming beauty scraping oil and preparation method thereof |
| 01/16/2013 | CN102150859B Composition with functions of relieving physical fatigue and improving memory as well as preparation method and application thereof |
| 01/16/2013 | CN102144987B Metoprolol oral pulsatile tablet and preparation method and application of metoprolol oral pulsatile tablet |
| 01/16/2013 | CN102133394B Compound insulin preparation |
| 01/16/2013 | CN102133201B Faropenem sodium freeze-dried powder injection |
| 01/16/2013 | CN102125522B P-glycoprotein monoclonal antibody modified phenytoin targeting nanopreparation and preparation method thereof |
| 01/16/2013 | CN102106852B Medicinal use of 2'2-bithiazole non-nucleoside compounds serving as hepatitis C virus inhibitor |
| 01/16/2013 | CN102093424B Platinum coordination compound of anti-tumor medicaments |
| 01/16/2013 | CN102080085B Human miR-193b antisense nucleotide and application thereof |
| 01/16/2013 | CN102078516B Traditional Chinese medicine for treating bone injury |
| 01/16/2013 | CN102058817B Tibetan medicinal preparation for treating liver diseases |
| 01/16/2013 | CN102006864B Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 01/16/2013 | CN101977611B Improved method and process for synthesis of 2',3'-didehydro-2',3'-dideoxynucleosides |
| 01/16/2013 | CN101969961B Combined use of cholestanol derivative |
| 01/16/2013 | CN101945653B Compositions and methods for treating neurodegenerative diseases |
| 01/16/2013 | CN101935295B Method for extracting active ingredients from papaya seeds |
| 01/16/2013 | CN101921236B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/16/2013 | CN101912611B Drug composition with anti-tumor effect |
| 01/16/2013 | CN101906128B Estrone compound, as well as preparation method and application thereof |
| 01/16/2013 | CN101906105B Pyrazolo (1,5-a) pyrimidone derivative as well as drug combination thereof and application thereof |
| 01/16/2013 | CN101899011B Dithiocarbamates compound, preparation method and application thereof |
| 01/16/2013 | CN101891769B Anti-tumor platinum complexes |
| 01/16/2013 | CN101890001B Medicinal composition of bifendate |
| 01/16/2013 | CN101878027B Multitarget compounds active at a PPAR and cannabinoid receptor |
| 01/16/2013 | CN101869633B Enteric-coated medicament combination containing epigallocatechin gallate |
| 01/16/2013 | CN101820872B Use of ricinoleic acid monoglyceride in antimicrobial agent and method for improving antimicrobial agent |
| 01/16/2013 | CN101815510B Pharmaceutical preparations containing highly volatile silicones |
| 01/16/2013 | CN101773481B Chewable tablet containing montelukast sodium |
| 01/16/2013 | CN101747253B Trisubstituted chiral lactam derivative and preparation method and application thereof |
| 01/16/2013 | CN101732645B External preparation for treating abdominal pain and preparation method thereof |
| 01/16/2013 | CN101730690B Sulfonamide compound, and crystal thereof |
| 01/16/2013 | CN101711244B 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 01/16/2013 | CN101677976B Use of activator of AMP-activated protein kinase in preparing medicine for inhibiting HIV replication |
| 01/16/2013 | CN101663033B Triazole derivatives which are SMO antagonists |
| 01/16/2013 | CN101641365B Novel sulfonated sugar derivative, and use thereof for medicinal agent |
| 01/16/2013 | CN101641088B Treatment of gastrointestinal diseases |
| 01/16/2013 | CN101610772B Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
| 01/16/2013 | CN101522669B Therapeutic lactams |
| 01/16/2013 | CN101480376B Method of preparing particles for agglomeration |
| 01/16/2013 | CN101454011B Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 01/16/2013 | CN101352449B 维生素口腔崩解片及其制备方法 Vitamin orally disintegrating tablets and preparation method |
| 01/16/2013 | CN101336958B Use of alkaloids extracted from sophora flavescens in preparing medicine for treating diseased induced by mycoplasma, chlamydia and fungus |
| 01/16/2013 | CN101325944B Compositions for nasal delivery |
| 01/16/2013 | CN101322683B Gel for eye containing bromfenac sodium hydrate and preparation thereof |
| 01/16/2013 | CN101306191B Use of TLR2 ligand PGN in treating metabolism syndrome |
| 01/16/2013 | CN101128455B Heterocyclylamide-substituted imidazoles |
| 01/16/2013 | CN101115755B Pyrazolo-pyrimidine derivatives as MGLUR2 antagonists |
| 01/16/2013 | CN101074218B Cephalotamannine derivative, its production, its medicinal composition and use |
| 01/15/2013 | USRE43932 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/15/2013 | US8354550 Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof |
| 01/15/2013 | US8354549 Method for preparing a polymer conjugate |
| 01/15/2013 | US8354545 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/15/2013 | US8354539 Indole derivatives as IKK2 inhibitors |
| 01/15/2013 | US8354535 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives |
| 01/15/2013 | US8354524 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 01/15/2013 | US8354521 Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma |
| 01/15/2013 | US8354455 Prodrugs containing novel bio-cleavable linkers |
| 01/15/2013 | US8354454 Prodrugs of oxazolidinone CETP inhibitors |
| 01/15/2013 | US8354453 Bupropion hydrobromide and therapeutic applications |
| 01/15/2013 | US8354452 Compositions and methods for treating diabetes and neuropsychological dysfunction |
| 01/15/2013 | US8354451 Treatment of microbial infections with compounds that inhibit 4-hydroxyphenylpyruvate dioxygenase |
| 01/15/2013 | US8354450 Creatine oral supplementation using creatine hydrochloride salt |
| 01/15/2013 | US8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
| 01/15/2013 | US8354447 mGLU receptors antagonists for treating disorders associated with mGLU receptors including addiction and depression |
| 01/15/2013 | US8354446 Selective androgen receptor modulators (SARMs) and uses thereof |